$1.99
-0.02-1%
At close: Nov 11, 4:00 PM EST
$1.95
-0.0562-2.8%
Pre-Market: 7:51 AM EST
Fortress Biotech Inc
FBIONASDAQ
Fortress Biotech fell 19.3% from $2.49 to $2.01, behind the S&P 500's +12.7%. Its worst day was Jan 14 (−15.9%), and its low came Nov 5 at $1.84.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.11 beat the $-0.55 estimate on $17.6M revenue (est. $22.1M).
+5.2% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
Fortress Biotech shares rose 13.3%, while the S&P 500 fell 0.2%.
+13.3%, the year's best day · S&P 500 −0.2%
Fortress Biotech closed at its highest level of the year, 75.9% above where the year started.
+2.6% · S&P 500 0.0%
Fortress Biotech shares rose 11.9%, while the S&P 500 rose 0.5%.
+11.9% · S&P 500 +0.5%
EPS of $-0.30 missed the $0.23 estimate on $16.1M revenue (est. $29.1M).
−11.5% · S&P 500 +0.8%
EPS of $2.82 beat the $-0.08 estimate on $16.0M revenue (est. $16.3M).
+4.8% · S&P 500 −1.2%
Fortress Biotech shares rose 13.0%, while the S&P 500 rose 0.4%.
+13.0% · S&P 500 +0.4%
Fortress Biotech shares fell 11.8%, while the S&P 500 rose 1.4%.
−11.8% · S&P 500 +1.4%
EPS of $-0.08 beat the $-0.20 estimate on $18.7M revenue (est. $18.3M).
−1.7% · S&P 500 −0.2%
Fortress Biotech closed at its lowest level of the year, 26.1% below where the year started.
−6.6% · S&P 500 −4.4%
Where it ended: a close of $2.01 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 13, 2026 (EPS est. $-0.27, revenue est. $21.6M).
Nothing in the past 12 months.
All FBIO analyst actionsNothing in the past 12 months.
All FBIO dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for FBIO and SPY from Benzinga historical bars. Not investment advice.
